6-(4-bromoacetamidobenzyl)-1,4,8,11-tetraazacyclotetradecane-n,n',n'',n'''-tetraacetic acid has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, CJ; Connett, JM; Guo, LW; Meares, CF; Philpott, GW; Rocque, PA; Schwarz, SW; Welch, MJ; Zinn, KR | 1 |
1 other study(ies) available for 6-(4-bromoacetamidobenzyl)-1,4,8,11-tetraazacyclotetradecane-n,n',n'',n'''-tetraacetic acid and Colonic Neoplasms
Article | Year |
---|---|
Copper-64-labeled antibodies for PET imaging.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Colonic Neoplasms; Copper Radioisotopes; Cricetinae; Edetic Acid; Female; Heterocyclic Compounds; Humans; Immunoglobulin Fab Fragments; Indium Radioisotopes; Iodine Radioisotopes; Male; Mesocricetus; Rats; Rats, Inbred Strains; Tomography, Emission-Computed | 1992 |